A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancie (Q35000494)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancie |
scientific article |
Statements
1 reference
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancie (English)
1 reference
Lydia Usha
1 reference
Michael W Sill
1 reference
Kathleen M Darcy
1 reference
Doris M Benbrook
1 reference
Jean A Hurteau
1 reference
David P Michelin
1 reference
Robert S Mannel
1 reference
Parviz Hanjani
1 reference
Koen De Geest
1 reference
Andrew K Godwin
1 reference
17 March 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference